IP Library Assignment 022024/0492
Patent Assignment
Reel/Frame 022024/0492

License

Recorded: 2008-12-24 Pages: 3
Assignor
Assignee
SANOFI-AVENTIS U.S. LLC
55 CORPORATE DRIVE, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties (17)
Modified Release Formulations of a Bupropion Salt
Patent: 7,241,805 →
Application: 11/475,252 →
Publication: US 2007/0027213
Modified Release Formulations of a Bupropion Salt
Patent: 7,569,610 →
Application: 11/751,768 →
Publication: US 2007/0276047
Modified Release Formulations of a Bupropion Salt
Patent: 7,563,823 →
Application: 11/751,785 →
Publication: US 2007/0269516
Modified Release Formulations of a Bupropion Salt
Patent: 7,553,992 →
Application: 11/755,946 →
Publication: US 2008/0051606
Modified Release Formulations of a Bupropion Salt
Patent: 7,649,019 →
Application: 11/759,413 →
Publication: US 2008/0057120
Modified Release Formulations of a Bupropion Salt
Patent: 8,932,628 →
Application: 11/762,343 →
Publication: US 2008/0038348
Modified Release Formulations of a Bupropion Salt
Application: 11/762,368 →
Publication: US 2007/0281012
Modified Release Formulations of a Bupropion Salt
Patent: 7,569,611 →
Application: 11/762,820 →
Publication: US 2008/0039441
Modified Release Formulations of a Bupropion Salt
Patent: 7,572,935 →
Application: 11/762,840 →
Publication: US 2008/0033043
Modified Release Formulations of a Bupropion Salt
Patent: 7,645,901 →
Application: 11/766,213 →
Publication: US 2008/0033044
Modified Release Formulations of a Bupropion Salt
Patent: 7,585,897 →
Application: 11/766,239 →
Publication: US 2008/0081068
Modified Release Formulations of a Bupropion Salt
Patent: 7,662,407 →
Application: 11/766,251 →
Publication: US 2007/0293584
Modified Release Formulations of a Bupropion Salt
Patent: 7,579,380 →
Application: 11/774,109 →
Publication: US 2008/0038345
Bupropion Hydrobromide and Therapeutic Applications
Patent: 7,671,094 →
Application: 11/834,848 →
Publication: US 2008/0075774
Bupropion Hydrobromide and Therapeutic Applications
Patent: 7,645,802 →
Application: 11/930,644 →
Publication: US 2008/0274181
Modified-Release Formulations of a Bupropion Salt
Patent: 7,884,136 →
Application: 11/993,723 →
Publication: US 2010/0222435
Bupropion hydrobromide and medicaments and uses thereof
Application: 60/693,906 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 24, 2007
From: OBEREGGER, WERNER; ZHOU, FANG; MASSARDO, PIETRO; MAES, PAUL
To: BIOVAIL LABORATORIES INTERNATIONAL S.R.L.
Reel/Frame 019597/0823 →
Assignment of Assignor's Interest Nov 27, 2007
From: WILLIAMS, ROBERT PARRY; SILVERSTONE, PETER HARRIS
To: BIOVAIL LABORATORIES INTERNATIONAL S.R.L.
Reel/Frame 020155/0153 →
Assignment of Assignor's Interest Feb 19, 2008
From: OBEREGGER, WERNER; ZHOU, FANG; MASSARDO, PIETRO; MAES, PAUL
To: BIOVAIL LABORATORIES INTERNATIONAL S.R.L.
Reel/Frame 020528/0726 →
Assignment of Assignor's Interest Mar 27, 2008
From: OBEREGGER, WERNER; MAES, PAUL; SALEH, MOHAMMAD ASHTY
To: BIOVAIL LABORATORIES INTERNATIONAL SRL
Reel/Frame 020708/0980 →
Assignment of Assignor's Interest Feb 12, 2009
From: JACKSON, GRAHAM
To: BIOVAIL LABORATORIES INTERNATIONAL S.R.L.
Reel/Frame 022250/0123 →
Corrective Assignment to Correct the Assignee's Address Previously Recorded on Reel 022250 Frame 0123. Assignor(S) Hereby Confirms the Assignment. Feb 23, 2009
From: JACKSON, GRAHAM
To: BIOVAIL LABORATORIES INTERNATIONAL SRL.
Reel/Frame 022293/0725 →
Patent and Trademark Security Agreement Jun 11, 2009
From: BIOVAIL LABORATORIES INTERNATIONAL SRL
To: J.P. MORGAN CHASE BANK, N.A., TORONTO BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 022813/0195 →
Security Agreement Oct 4, 2010
From: BIOVAIL INTERNATIONAL LABORATORIES SRL; BIOVAIL INTERNATIONAL LABORATORIES (BARBADOS) SRL
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0022 →
Release of Security Agreement Oct 6, 2010
From: JPMORGAN CHASE BANK, N.A., TORONTO BRANCH
To: BIOVAIL CORPORATION; BIOVAIL LABORATORIES INTERNATIONAL SRL
Reel/Frame 025095/0479 →
Patent Security Release Agreement Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: BIOVAIL INTERNATIONAL LABORATORIES SRL; BIOVAIL INTERNATIONAL LABORATORIES (BARBADOS) SRL
Reel/Frame 025950/0073 →
Change of Name Jun 7, 2011
From: BIOVAIL LABORATORIES INTERNATIONAL SRL
To: VALEANT INTERNATIONAL (BARBADOS) SRL
Reel/Frame 026404/0095 →
Security Agreement Jul 18, 2011
From: VALEANT INTERNATIONAL (BARBADOS) SRL, A BARBADOS INTERNATIONAL SOCIETY WITH RESTRICTED LIABILITY; BIOVALE LABORATORIES INTERNATIONAL (BARBADOS) SRL, A BARBADOS INTERNATIONAL SOCIETY WITH RESTRICTED LIABILITY
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 026605/0801 →
Change in Name and Country of Incorporation Aug 9, 2012
From: VALEANT INTERNATIONAL (BARBADOS) SRL
To: VALEANT INTERNATIONAL BERMUDA
Reel/Frame 028757/0052 →
Notice of Succession of Agency Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Intellectual Property Security Agreement Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Security Interest Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Security Interest Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Security Agreement (First Lien) Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien) Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Agreement (Second Lien) Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
Security Agreement (First Lien) Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Assignment of Assignor's Interest May 1, 2025
From: WERNER, OBEREGGER; ZHOU, FANG; MASSARDO, PIETRO; MAES, PAUL
To: BIOVAIL LABORATORIES INTERNATIONAL S.R.L.
Reel/Frame 071146/0872 →